GR
GRAIL Inc.
GRAL · NASDAQ
$126.89 +2.74% (+$3.39)
1M +59.87%
Market Cap $4.63B
P/E Ratio -
Div. Yield -
ROE 15.88%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Moderate
4/9Valuation
46 /100
Fair P/S 28.04x
P/B 1.82x
P/E N/A
Growth
78 /100
Growing Rev. growth 38.37%
Book val. growth 17.83%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 10.83%
Net margin 236.95%
Op. margin 338.40%
Quality
1 /100
Poor ROIC 14.93%
ROE 15.88%
ROA 13.77%
Debt
100 /100
Low Debt/Equity 0.04x
Current ratio 10.95x
Int. coverage N/A
Stability
19 /100
Unstable Beta 3.25x
Rev. volatility 25.58%
EPS volatility 65.02%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GRAL
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Joshua J. Ofman
Employees
910
Headquarters
Menlo Park
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report